Smoking Cannabis May Cut Your Risk Of Non-Alcoholic Fatty Liver Disease: Study

Add non-alcoholic fatty liver disease (NAFLD) to the list of conditions that cannabis can help curb. 

A new study published in the journal PLoS One found that cannabis-friendly adults are less likely to develop the most prevalent form of liver disease – affecting 80 to 100 million Americans – than those without a history of cannabis use.  

Researchers from California’s Stanford University and South Korea’s Seoul National University College of Medicine looked at the relationship between cannabis and NAFLD in a nationally representative sample of more than 22,000 adults.

They found that cannabis use independently predicted a lower risk of suspected NAFLD in a dose-dependent manner.

“Active marijuana use provided a protective effect against NAFLD independent of known metabolic risk factors,” reads the study.

“[W]e conclude that current marijuana use may favorably impact the pathogenesis of NAFLD in US adults.”

These results reflect a study previously published in the same journal, which found that heavy cannabis consumers were 52 percent less likely – and occasional consumers 15 percent less likely – than non-users to suffer from NAFLD.

Another study published earlier this month in the Journal of Viral Hepatitis found that routine cannabis use is linked with a reduced prevalence of fatty liver disease in those with HIV and hepatitis C.

h/t NORML blog

Latest.

The safest way to consume cannabis is through edibles, according to the average American. That's what researchers found after a recent survey 9,000 respondents across the United States. The study - which has been published in the Journal of General Internal Medicine - discovered that 25 percent of respondents picked cannabis-infused edibles as the safest form of marijuana consumption.